LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1426 | 4203 | 0.3400 | 0.0963 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3931 | 4203 | 0.9357 | 0.9273 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3388 | 4203 | 0.8081 | 0.7768 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 566 | 4203 | 0.1350 | -0.3455 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4412 | 4203 | 1.0522 | 1.0586 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4175 | 4203 | 0.9932 | 0.9920 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4156 | 4203 | 0.9898 | 0.9893 |
MCF7 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3824 | 4203 | 0.9113 | 0.8991 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3332 | 4203 | 0.7963 | 0.7620 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1209 | 1742 | 4203 | 0.4146 | 0.2244 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3813 | 4203 | 0.9088 | 0.8972 |
MCF7 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3746 | 4203 | 0.8906 | 0.8736 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3529 | 4203 | 0.8399 | 0.8145 |
MCF7 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3699 | 4203 | 0.8820 | 0.8656 |
MCF7 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3762 | 4203 | 0.8966 | 0.8829 |
MCF7 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1209 | 2778 | 4203 | 0.6601 | 0.5857 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1209 | 569 | 4203 | 0.1358 | -0.3430 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2753 | 4203 | 0.6563 | 0.5821 |
MCF7 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1594 | 4203 | 0.3800 | 0.1664 |
MCF7 | Neratinib | 10 | uM | LJP5 | 72 | hr | 1209 | 1377 | 4203 | 0.3283 | 0.0751 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3206 | 4203 | 0.7621 | 0.7182 |
MCF7 | Seliciclib | 10 | uM | LJP5 | 72 | hr | 1209 | 1223 | 4203 | 0.2908 | 0.0047 |
MCF7 | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1209 | 1660 | 4203 | 0.3954 | 0.1920 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3523 | 4203 | 0.8394 | 0.8147 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3621 | 4203 | 0.8617 | 0.8409 |